Clinical Trial Update: A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating MK-2870 alone or with other therapies for gastrointestinal cancers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Colorectal Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• MK-2870

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Colorectal Cancer, Pancreatic Ductal Adenocarcinoma | Phase 1, Phase 2 | Status: RECRUITING